BAL PHARMA
Back to Balance Sheet
|
BAL PHARMA Last 5 Year Net Current Assets History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Current Assets (Including Current Investments) | ₹31 Cr | ₹19 Cr | ₹19 Cr | ₹12 Cr | ₹-2.12 Cr |
What is the latest Net Current Assets ratio of BAL PHARMA ?
Year | Net Current Assets |
---|---|
Mar2024 | ₹31 Cr |
Mar2023 | ₹19 Cr |
Mar2022 | ₹19 Cr |
Mar2021 | ₹12 Cr |
Mar2020 | ₹-2.12 Cr |
How is Net Current Assets of BAL PHARMA Trending?
Years | Net Current Assets | % Change | |
---|---|---|---|
Mar2024 | ₹31 Cr | 65.25 | |
Mar2023 | ₹19 Cr | -0.55 | |
Mar2022 | ₹19 Cr | 62.96 | |
Mar2021 | ₹12 Cr | Positive | |
Mar2020 | ₹-2.12 Cr | - |
Compare Net Current Assets of peers of BAL PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BAL PHARMA | ₹166.2 Cr | 0.1% | 26.9% | 2.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹420,136.0 Cr | 6% | 4% | 9.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹149,680.0 Cr | 4.7% | 0.3% | 52.4% | Stock Analytics | |
CIPLA | ₹122,394.0 Cr | 7% | 3.7% | 7.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,159.0 Cr | 4.1% | 6.4% | 25% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,105.6 Cr | 6.3% | 5% | -4.7% | Stock Analytics |
BAL PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BAL PHARMA | 0.1% |
26.9% |
2.9% |
SENSEX | 5.8% |
6.1% |
4.7% |
You may also like the below Video Courses